Vote Now
Research Grants - 2009


Alzheimer's Assocation Research only
All of alz.org
  • Go to Alz.org
  • Research Center
  • AAIC
  • ISTAART
  • Journal
  • Grants
  • TrialMatch
  • Press
  • Donate
  • Contact Us
Home
Science and Progress
Clinical Trials
Funding and Collaboration
You can Help
Stay Current
Video and Resources

Text Size

Small text Medium text Large text

Research Grants 2009


To view an abstract, select an author from the vertical list on the left.

2009 Grants - Van Nostrand

Molecular Seeding of Cerebral Amyloid Angiopathy in Novel Transgenic Mice

William E. Van Nostrand, Ph.D.
Stony Brook University
Stony Brook, New York

2009 New Investigator Research Grant

Cerebral amyloid angiopathy (CAA) is a condition in which amyloid plaques form inside the blood vessels of the brain instead of, or in addition to, within the brain matter itself. CAA is common in people with Alzheimer's disease, but certain genetic mutations are associated with early onset, severe CAA. These mutations occur in the gene for beta-amyloid, the protein fragment that forms the major constituent of amyloid plaques.

Most people with a genetic mutation causing CAA have one copy of the normal beta-amyloid gene and one copy of the mutated gene. In such cases, amyloid plaques arise from interactions between normal and mutant beta-amyloid. Because these interactions are not well understood, William E. Van Nostrand, Ph.D. and colleagues are studying this issue in mice that have been genetically altered to express both normal and mutant human beta-amyloid. The researchers will study how the two forms of beta-amyloid interact to produce amyloid deposits in the blood vessels of the brain, and how such deposits lead to cognitive impairments and brain hemorrhage. These studies will advance our understanding of CAA, and help to identify strategies for slowing or preventing progression of the disease.